| A Pin1/mutant p53 axis promotes aggressiveness in breast cancer JE Girardini, M Napoli, S Piazza, A Rustighi, C Marotta, E Radaelli, ... Cancer cell 20 (1), 79-91, 2011 | 360 | 2011 |
| Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS) AM Thompson, LB Jordan, P Quinlan, E Anderson, A Skene, JA Dewar, ... Breast cancer research 12, 1-9, 2010 | 312 | 2010 |
| Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study CA Purdie, P Quinlan, LB Jordan, A Ashfield, S Ogston, JA Dewar, ... British journal of cancer 110 (3), 565-572, 2014 | 255 | 2014 |
| Histological evaluation of AMPK signalling in primary breast cancer SM Hadad, L Baker, PR Quinlan, KE Robertson, SE Bray, G Thomson, ... BMC cancer 9, 1-9, 2009 | 208 | 2009 |
| Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies E Amir, M Clemons, CA Purdie, N Miller, P Quinlan, W Geddie, ... Cancer treatment reviews 38 (6), 708-714, 2012 | 206 | 2012 |
| CYP2D6 Genotype and Adjuvant Tamoxifen: Meta‐Analysis of Heterogeneous Study Populations MA Province, MP Goetz, H Brauch, DA Flockhart, JM Hebert, R Whaley, ... Clinical Pharmacology & Therapeutics 95 (2), 216-227, 2014 | 203 | 2014 |
| Therapeutic targeting of integrin αvβ6 in breast cancer KM Moore, GJ Thomas, SW Duffy, J Warwick, R Gabe, P Chou, IO Ellis, ... Journal of the National Cancer Institute 106 (8), dju169, 2014 | 167 | 2014 |
| A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences AM Shaaban, GR Ball, RA Brannan, G Cserni, AD Benedetto, J Dent, ... Breast cancer research and treatment 133, 949-958, 2012 | 150 | 2012 |
| p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients JC Bourdon, MP Khoury, A Diot, L Baker, K Fernandes, M Aoubala, ... Breast Cancer Research 13, 1-10, 2011 | 133 | 2011 |
| Immunohistochemical detection of Polo-like kinase-1 (PLK1) in primary breast cancer is associated with TP53mutation and poor clinical outcome SI King, CA Purdie, SE Bray, PR Quinlan, LB Jordan, AM Thompson, ... Breast cancer research 14, 1-11, 2012 | 118 | 2012 |
| ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR C Thomas, G Rajapaksa, F Nikolos, R Hao, A Katchy, CW McCollum, ... Breast cancer research 14, 1-15, 2012 | 114 | 2012 |
| High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer PG Roy, N Pratt, CA Purdie, L Baker, A Ashfield, P Quinlan, ... International journal of cancer 127 (2), 355-360, 2010 | 108 | 2010 |
| Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy AM Thompson, A Johnson, P Quinlan, G Hillman, M Fontecha, SE Bray, ... Breast cancer research and treatment 125, 279-287, 2011 | 100 | 2011 |
| p53 mutation, deprivation and poor prognosis in primary breast cancer L Baker, PR Quinlan, N Patten, A Ashfield, LJ Birse-Stewart-Bell, ... British journal of cancer 102 (4), 719-726, 2010 | 81 | 2010 |
| Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome LA Henry, DA Johnson, D Sarrió, S Lee, PR Quinlan, T Crook, ... Oncogene 30 (9), 1046-1058, 2011 | 79 | 2011 |
| The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer R Shah, P Smith, C Purdie, P Quinlan, L Baker, P Aman, AM Thompson, ... British journal of cancer 100 (10), 1687-1696, 2009 | 71 | 2009 |
| TP53 drives invasion through expression of its Δ133p53β variant G Gadea, N Arsic, K Fernandes, A Diot, SM Joruiz, S Abdallah, V Meuray, ... Elife 5, e14734, 2016 | 65 | 2016 |
| Connectionism and learning to read: Steps towards a psychologically plausible model C Hulme, M Snowling, P Quinlan Reading and Writing 3, 159-168, 1991 | 60 | 1991 |
| MAGE-A cancer/testis antigens inhibit MDM2 ubiquitylation function and promote increased levels of MDM4 L Marcar, B Ihrig, J Hourihan, SE Bray, PR Quinlan, LB Jordan, ... PloS one 10 (5), e0127713, 2015 | 58 | 2015 |
| High frequency of complex TP53 mutations in CNS metastases from breast cancer C Lo Nigro, D Vivenza, M Monteverde, L Lattanzio, O Gojis, O Garrone, ... British journal of cancer 106 (2), 397-404, 2012 | 56 | 2012 |
